JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 2009; 109:1167-1173
© 2009 International Anesthesia Research Society
doi: 10.1213/ANE.0b013e3181b5ae2d
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Klingler, W.
Right arrow Articles by Hopkins, P. M.
PubMed
Right arrow Articles by Klingler, W.
Right arrow Articles by Hopkins, P. M.
Related Collections
Right arrow Mechanisms
Right arrow Complications
Right arrow Patient Safety
Right arrow Preclinical Pharmacology
Right arrow Clinical Pharmacology
Right arrow Malignant Hyperthermia
Right arrow Pediatrics
Right arrow Pharmacology


PATIENT SAFETY

Core Myopathies and Risk of Malignant Hyperthermia

Werner Klingler, MD*{dagger}, Henrik Rueffert, MD{ddagger}, Frank Lehmann-Horn, MD{dagger}, Thierry Girard, MD§, and Philip M. Hopkins, MD||

From the Departments of *Anaesthesiology, and {dagger}Applied Physiology, University of Ulm, Ulm, Germany; {ddagger}Department of Anaesthesiology and Intensive Care Medicine, University of Leipzig, Leipzig, Germany; §Department of Anaesthesia, University Hospital of Basel, Basel, Switzerland; and ||Academic Unit of Anaesthesia, St. James's University Hospital, Leeds, UK.

Address correspondence and reprint requests to Philip M. Hopkins, MD, Academic Unit of Anaesthesia, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK. Address e-mail to p.m.hopkins{at}leeds.ac.uk.

Abstract

In this article, we analyze myopathies with cores, for which an association to malignant hyperthermia (MH) has been suggested. We discuss the clinical features, the underlying genetic defects, subsequent effects on cellular calcium metabolism, and in vitro muscle responses to MH triggers. We describe in detail central core disease, multiminicore disease, and nemaline rod myopathy. We categorize the diseases according to the affected proteins and discuss the risk for MH, which is high or theoretically possible when the calcium-conducting proteins are affected.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
P. J. Davis and B. W. Brandom
The Association of Malignant Hyperthermia and Unusual Disease: When You're Hot You're Hot, or Maybe Not
Anesth. Analg., October 1, 2009; 109(4): 1001 - 1003.
[Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2009 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2009 by the International Anesthesia Research Society.